Functionality of unspliced XBP1 is required to explain evolution of overlapping reading frames

Trends in Genetics

Volumn 22, Issue 12, 2006, Pages 645-648

  Nekrutenko, Anton ^a   He, Jianbin ^a  

^a PENNSYLVANIA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN IRE1; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; X BOX PROTEIN 1;

AMINO ACID SUBSTITUTION; GENE IDENTIFICATION; GENE LOCUS; GENE SWITCHING; GENETIC CONSERVATION; GENETIC TRANSCRIPTION; HUMAN; MOLECULAR EVOLUTION; NONHUMAN; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA SPLICING; RNA TRANSLATION; SHORT SURVEY;

ANIMALS; BASE SEQUENCE; BASIC-LEUCINE ZIPPER TRANSCRIPTION FACTORS; CAENORHABDITIS ELEGANS; DNA-BINDING PROTEINS; EVOLUTION, MOLECULAR; HUMANS; MICE; MOLECULAR SEQUENCE DATA; NUCLEAR PROTEINS; NUCLEOTIDES; OPEN READING FRAMES; PROTEIN DENATURATION; REPRESSOR PROTEINS; RNA SPLICING; RNA, MESSENGER; SACCHAROMYCES CEREVISIAE PROTEINS; SIGNAL TRANSDUCTION;

EUKARYOTA;

EID: 33750935613     PISSN: 01689525     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tig.2006.09.012     Document Type: Short Survey

References (19)

1. Schroder M., and Kaufman R.J. The mammalian unfolded protein response. Annu. Rev. Biochem. 74 (2005) 739-789
2. Mori K. Frame switch splicing and regulated intramembrane proteolysis: key words to understand the unfolded protein response. Traffic 4 (2003) 519-528
3. Yoshida H., et al. XBP1 mRNA is induced by ATF6 and spliced by IRE1 in response to ER stress to produce a highly active transcription factor. Cell 107 (2001) 881-891
4. Calfon M., et al. IRE1 couples endoplasmic reticulum load to secretory capacity by processing the XBP-1 mRNA. Nature 415 (2002) 92-96
5. Harding H.P., et al. Transcriptional and translational control in the mammalian unfolded protein response. Annu. Rev. Cell Dev. Biol. 18 (2002) 575-599
6. Ruegsegger U., et al. Block of HAC1 mRNA translation by long-range base pairing is released by cytoplasmic splicing upon induction of the unfolded protein response. Cell 107 (2001) 103-114
7. Ding L., et al. Ligand-independent activation of estrogen receptor alpha by XBP-1. Nucleic Acids Res. 31 (2003) 5266-5274
8. Fang Y., et al. XBP-1 increases ERα transcriptional activity through regulation of large-scale chromatin unfolding. Biochem. Biophys. Res. Commun. 323 (2004) 269-274
9. Tirosh B., et al. Rapid turnover of unspliced xbp-1 as a factor that modulates the unfolded protein response. J. Biol. Chem. 281 (2006) 5852-5860
10. Shen X., et al. Genetic interactions due to constitutive and inducible gene regulation mediated by the unfolded protein response in C. elegans. PLoS Genet 1 (2005) e37
11. Yoshida H., et al. pXBP1(U) encoded in XBP1 pre-mRNA negatively regulates unfolded protein response activator pXBP1(S) in mammalian ER stress response. J. Cell Biol. 172 (2006) 565-575
12. Nekrutenko A., et al. Oscillating evolution of a mammalian locus with overlapping reading frames: an XLαS/ALEX Relay. PLoS Genet 1 (2005) e18
13. Gonzalez T.N., et al. Mechanism of non-spliceosomal mRNA splicing in the unfolded protein response pathway. EMBO J. 18 (1999) 3119-3132
14. Li W.H. Molecular Evolution (1997), Sinauer
15. Niwa M., et al. Genome-scale approaches for discovering novel nonconventional splicing substrates of the Ire1 nuclease. Genome Biol. 6 (2005) R3
16. Hollien J., and Weissman J.S. Decay of endoplasmic reticulum-localized mRNAs during the unfolded protein response. Science 313 (2006) 104-107
17. Klemke M., et al. Two overlapping reading frames in a single exon encode interacting proteins - a novel way of gene usage. EMBO J. 20 (2001) 3849-3860
18. Quelle D.E., et al. Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest. Cell 83 (1995) 993-1000
19. Freson K., et al. Functional polymorphisms in the paternally expressed XLαS and its cofactor ALEX decrease their mutual interaction and enhance receptor-mediated cAMP formation. Hum. Mol. Genet. 12 (2003) 1121-1130